C
Ching-Yee Loo
Researcher at Woolcock Institute of Medical Research
Publications - 48
Citations - 2623
Ching-Yee Loo is an academic researcher from Woolcock Institute of Medical Research. The author has contributed to research in topics: Curcumin & Lung cancer. The author has an hindex of 25, co-authored 41 publications receiving 2117 citations. Previous affiliations of Ching-Yee Loo include University of Sydney & Universiti Sains Malaysia.
Papers
More filters
Journal ArticleDOI
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.
TL;DR: This review focuses in detail on the effectiveness of curcumin and its mechanism of actions in treating neurodegenerative diseases such as Alzheimer's and Parkinson’s diseases and brain malignancies.
Journal ArticleDOI
Recent advances in curcumin nanoformulation for cancer therapy.
TL;DR: This review focuses on the development of curcumin nano-particle formulation to improve its therapeutic index through enhanced cellular uptake, localization to targeted areas and improved bioavailability.
Journal ArticleDOI
Biosynthesis of polyhydroxyalkanoate copolymers from mixtures of plant oils and 3-hydroxyvalerate precursors.
TL;DR: Sodium propionate appears to be the better precursor of 3HV than sodium valerate, and PHA copolymers with high weight-average molecular weights ranging from 1,400,000 to 3,100,000Da were successfully produced from mixtures of plant oils and3HV-precursors.
Journal ArticleDOI
Biosynthesis and characterization of poly(3-hydroxybutyrate-co-3- hydroxyhexanoate) from palm oil products in a Wautersia eutropha mutant.
TL;DR: Gravimetric and microscopic analyses further confirmed the high PHA content in the recombinant cells and the molar fraction of 3HHx remained constant at 5 mol % regardless of the type and concentration of palm oil products used.
Journal ArticleDOI
Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges
TL;DR: This review will focus on the current inhalable nano-based drugs for lung cancer treatment, and Pharmacology, immunology, toxicology and large-scale manufacturing are some aspects in nanotechnology that should be taken into consideration for the development of inhalable Nano-based chemotherapeutic drugs.